Cite
APA Citation
Ding, X., Stasi, L. P., Dai, X., Long, K., Peng, C., Zhao, B., Wang, H., Sun, C., Hu, H., Wan, Z., Jandu, K. S., Philps, O. J., Chen, Y., Wang, L., Liu, Q., Edge, C., Li, Y., Dong, K., Guan, X., Tattersall, F. D., Reith, A. D., & Ren, F. (2019). 5-Substituted-N-pyridazinylbenzamides as potent and selective LRRK2 inhibitors: Improved brain unbound fraction enables efficacy. Bioorganic & medicinal chemistry letters, 29(2), 212–215. http://access.bl.uk/ark:/81055/vdc_100076297280.0x000020